N. Farfán

454 total citations
12 papers, 382 citations indexed

About

N. Farfán is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, N. Farfán has authored 12 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Surgery. Recurrent topics in N. Farfán's work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). N. Farfán is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). N. Farfán collaborates with scholars based in Chile, United States and Spain. N. Farfán's co-authors include Caroll J. Beltrán, Marcela A. Hermoso, David Díaz-Jiménez, Rodrigo Quera, Lucía Núñez, Enzo Candía, Francisco López, Marı́a Julieta González, José A. G. Agúndez and Nelson Varela and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

N. Farfán

12 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Farfán Chile 7 186 148 74 69 55 12 382
Ziqin Yin Canada 12 166 0.9× 87 0.6× 36 0.5× 184 2.7× 29 0.5× 13 440
Masato Komai Japan 11 232 1.2× 70 0.5× 18 0.2× 68 1.0× 49 0.9× 14 625
Nancy M. Benight United States 13 97 0.5× 48 0.3× 38 0.5× 139 2.0× 74 1.3× 16 394
Shuyun Zheng China 12 49 0.3× 70 0.5× 20 0.3× 174 2.5× 54 1.0× 31 412
Junji Kasanuki Japan 9 66 0.4× 189 1.3× 105 1.4× 58 0.8× 33 0.6× 17 436
И. В. Андрианова Russia 12 105 0.6× 86 0.6× 16 0.2× 125 1.8× 23 0.4× 46 405
Sitang Ge China 10 50 0.3× 121 0.8× 55 0.7× 81 1.2× 140 2.5× 27 318
Cheng-Wan Li China 13 126 0.7× 50 0.3× 21 0.3× 217 3.1× 57 1.0× 14 431
Yasuyuki Shinozaki Japan 11 67 0.4× 35 0.2× 30 0.4× 146 2.1× 26 0.5× 22 359
Marc C. Hansel United States 9 28 0.2× 208 1.4× 72 1.0× 190 2.8× 25 0.5× 11 600

Countries citing papers authored by N. Farfán

Since Specialization
Citations

This map shows the geographic impact of N. Farfán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Farfán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Farfán more than expected).

Fields of papers citing papers by N. Farfán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Farfán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Farfán. The network helps show where N. Farfán may publish in the future.

Co-authorship network of co-authors of N. Farfán

This figure shows the co-authorship network connecting the top 25 collaborators of N. Farfán. A scholar is included among the top collaborators of N. Farfán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Farfán. N. Farfán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Farfán, N., et al.. (2024). Potential of Cassava Clones for Iron, Zinc, and Selenium Biofortification. Agriculture. 14(2). 268–268. 5 indexed citations
2.
Farfán, N., Raúl Alvarado, Marı́a Elena Quintanilla, et al.. (2020). Intranasal Administration of Mesenchymal Stem Cell Secretome Reduces Hippocampal Oxidative Stress, Neuroinflammation and Cell Death, Improving the Behavioral Outcome Following Perinatal Asphyxia. International Journal of Molecular Sciences. 21(20). 7800–7800. 30 indexed citations
3.
Farfán, N., et al.. (2018). The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer. Scientific Reports. 8(1). 11467–11467. 20 indexed citations
4.
Roco, Ángela, Luis A. Quiñones, José A. G. Agúndez, et al.. (2012). Frequencies of 23 Functionally Significant Variant Alleles Related with Metabolism of Antineoplastic Drugs in the Chilean Population: Comparison with Caucasian and Asian Populations. Frontiers in Genetics. 3. 229–229. 57 indexed citations
5.
Candía, Enzo, David Díaz-Jiménez, Lucía Núñez, et al.. (2011). Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients. Immunobiology. 217(6). 634–642. 23 indexed citations
6.
Beltrán, Caroll J., Lucía Núñez, David Díaz-Jiménez, et al.. (2009). Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflammatory Bowel Diseases. 16(7). 1097–1107. 206 indexed citations
7.
Calfa, Carmen, G. Lopes, Gail Walker, et al.. (2008). Gemcitabine and oxaliplatin (GEMOX), a promissing combination for the treatment of relapsed, advanced or metastatic non small cell lung cancer (NSCLC). Journal of Clinical Oncology. 26(15_suppl). 19061–19061. 2 indexed citations
8.
Lopes, Gilberto, Alvaro J. Alencar, Marcelo Blaya, et al.. (2007). P2-280: Gemcitabine and Oxaliplatin as second and third line therapy of advanced and metastatic non-small cell lung cancer (NSCLC): evidence of clinical activity and improvement in quality of life.. Journal of Thoracic Oncology. 2(8). S683–S683. 1 indexed citations
9.
Alencar, Alvaro J., Marcelo Blaya, Luis E. Raez, et al.. (2007). Gemcitabine in combination with oxaliplatin as second-line therapy of advanced and metastatic NSCLC. Journal of Clinical Oncology. 25(18_suppl). 18157–18157. 1 indexed citations
10.
Farfán, N., et al.. (2007). Oxaliplatin and capecitabine (XELOX) as first-line therapy for metastatic or relapsed squamous cell carcinoma of the head and neck. Journal of Clinical Oncology. 25(18_suppl). 16524–16524. 1 indexed citations
11.
Raez, Luis E., Edgardo S. Santos, Gilberto Lopes, et al.. (2006). Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC). Lung Cancer. 53(3). 347–353. 18 indexed citations
12.
Sammán, Norma, et al.. (1999). Composition of Different Bean Varieties (Phaseolus vulgaris) of Northwestern Argentina (Region NOA):  Cultivation Zone Influence. Journal of Agricultural and Food Chemistry. 47(7). 2685–2689. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziqin Yin Breakdown of academic impact, for papers by Masato Komai Breakdown of academic impact, for papers by Nancy M. Benight Breakdown of academic impact, for papers by Shuyun Zheng Breakdown of academic impact, for papers by Junji Kasanuki Breakdown of academic impact, for papers by И. В. Андрианова Breakdown of academic impact, for papers by Sitang Ge Breakdown of academic impact, for papers by Cheng-Wan Li Breakdown of academic impact, for papers by Yasuyuki Shinozaki Breakdown of academic impact, for papers by Marc C. Hansel
Rankless by CCL
2026